Increased Levels of VCAM-1 in Patients with High Cardiovascular Risk and Obstructive Sleep Apnea Syndrome

(1) Background: Although obstructive sleep apnea (OSA) is associated with increased cardiovascular morbidity, the link between OSA and cardiovascular disease (CVD) is not completely elucidated. Thus, we aim to assess cardiovascular risk (CVR) using SCORE 2 and SCORE 2 for older persons (SCORE 2OP),...

Full description

Bibliographic Details
Main Authors: Ioana-Maria Chetan, Ștefan Cristian Vesa, Bianca Domokos Gergely, Ruxandra Stefana Beyer, Raluca Tomoaia, Georgiana Cabau, Damiana Maria Vulturar, Dana Pop, Doina Todea
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/12/1/48
_version_ 1797340077601325056
author Ioana-Maria Chetan
Ștefan Cristian Vesa
Bianca Domokos Gergely
Ruxandra Stefana Beyer
Raluca Tomoaia
Georgiana Cabau
Damiana Maria Vulturar
Dana Pop
Doina Todea
author_facet Ioana-Maria Chetan
Ștefan Cristian Vesa
Bianca Domokos Gergely
Ruxandra Stefana Beyer
Raluca Tomoaia
Georgiana Cabau
Damiana Maria Vulturar
Dana Pop
Doina Todea
author_sort Ioana-Maria Chetan
collection DOAJ
description (1) Background: Although obstructive sleep apnea (OSA) is associated with increased cardiovascular morbidity, the link between OSA and cardiovascular disease (CVD) is not completely elucidated. Thus, we aim to assess cardiovascular risk (CVR) using SCORE 2 and SCORE 2 for older persons (SCORE 2OP), and to evaluate the association between the endothelial biomarkers VCAM-1, ICAM-1, epicardial fat, and sleep study parameters in order to improve current clinical practices and better understand the short-and long-term CVRs in OSA patients. (2) Methods: 80 OSA patients and 37 healthy volunteers were enrolled in the study. SCORE2 and SCORE 2 OP regional risk charts (validated algorithms to predict the 10-year risk of first-onset CVD) were used for the analysis of CVR. Two-dimensional echocardiography was performed on all patients and epicardial fat thickness was measured. VCAM-1 and ICAM-1 serum levels were assessed in all patients. (3) Results: OSA patients were classified as being at high CVR, regardless of the type of score achieved. Increased EFT was observed in the OSA group. VCAM-1 was associated with a high CVR in OSA patients, but no significant correlation was observed between adhesion molecules and epicardial fat thickness. (4) Conclusions: OSA patients have a high CVR according to the SCORE 2 and SCORE 2OP risk scores. VCAM-1 may be associated with a high CVR in OSA patients. Extending conventional risk stratification scores by adding other potential biomarkers improves the risk stratification and guide treatment eligibility for CVD prevention in the OSA population.
first_indexed 2024-03-08T09:57:44Z
format Article
id doaj.art-53632a4431e1494c9e45c8cfe36c2ce0
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-08T09:57:44Z
publishDate 2023-12-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-53632a4431e1494c9e45c8cfe36c2ce02024-01-29T13:46:45ZengMDPI AGBiomedicines2227-90592023-12-011214810.3390/biomedicines12010048Increased Levels of VCAM-1 in Patients with High Cardiovascular Risk and Obstructive Sleep Apnea SyndromeIoana-Maria Chetan0Ștefan Cristian Vesa1Bianca Domokos Gergely2Ruxandra Stefana Beyer3Raluca Tomoaia4Georgiana Cabau5Damiana Maria Vulturar6Dana Pop7Doina Todea8Department of Pneumology, “Iuliu Hatieganu” University of Medicine and Pharmacy, 400012 Cluj-Napoca, RomaniaDepartment of Pharmacology, Toxicology and Clinical Pharmacology, “Iuliu Hatieganu” University of Medicine and Pharmacy, 400012 Cluj-Napoca, RomaniaDepartment of Pneumology, “Iuliu Hatieganu” University of Medicine and Pharmacy, 400012 Cluj-Napoca, RomaniaHeart Institute “Nicolae Stancioiu”, 400001 Cluj-Napoca, RomaniaDepartment of Cardiology, “Iuliu Hatieganu” University of Medicine and Pharmacy, 400012 Cluj-Napoca, RomaniaDepartment of Medical Genetics, “Iuliu Hatieganu” University of Medicine and Pharmacy, 400012 Cluj-Napoca, RomaniaDepartment of Pneumology, “Iuliu Hatieganu” University of Medicine and Pharmacy, 400012 Cluj-Napoca, RomaniaDepartment of Cardiology, “Iuliu Hatieganu” University of Medicine and Pharmacy, 400012 Cluj-Napoca, RomaniaDepartment of Pneumology, “Iuliu Hatieganu” University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania(1) Background: Although obstructive sleep apnea (OSA) is associated with increased cardiovascular morbidity, the link between OSA and cardiovascular disease (CVD) is not completely elucidated. Thus, we aim to assess cardiovascular risk (CVR) using SCORE 2 and SCORE 2 for older persons (SCORE 2OP), and to evaluate the association between the endothelial biomarkers VCAM-1, ICAM-1, epicardial fat, and sleep study parameters in order to improve current clinical practices and better understand the short-and long-term CVRs in OSA patients. (2) Methods: 80 OSA patients and 37 healthy volunteers were enrolled in the study. SCORE2 and SCORE 2 OP regional risk charts (validated algorithms to predict the 10-year risk of first-onset CVD) were used for the analysis of CVR. Two-dimensional echocardiography was performed on all patients and epicardial fat thickness was measured. VCAM-1 and ICAM-1 serum levels were assessed in all patients. (3) Results: OSA patients were classified as being at high CVR, regardless of the type of score achieved. Increased EFT was observed in the OSA group. VCAM-1 was associated with a high CVR in OSA patients, but no significant correlation was observed between adhesion molecules and epicardial fat thickness. (4) Conclusions: OSA patients have a high CVR according to the SCORE 2 and SCORE 2OP risk scores. VCAM-1 may be associated with a high CVR in OSA patients. Extending conventional risk stratification scores by adding other potential biomarkers improves the risk stratification and guide treatment eligibility for CVD prevention in the OSA population.https://www.mdpi.com/2227-9059/12/1/48cardiovascular riskobstructive sleep apnea syndromeVCAM-1ICAM-1epicardial fat thicknessSCORE2
spellingShingle Ioana-Maria Chetan
Ștefan Cristian Vesa
Bianca Domokos Gergely
Ruxandra Stefana Beyer
Raluca Tomoaia
Georgiana Cabau
Damiana Maria Vulturar
Dana Pop
Doina Todea
Increased Levels of VCAM-1 in Patients with High Cardiovascular Risk and Obstructive Sleep Apnea Syndrome
Biomedicines
cardiovascular risk
obstructive sleep apnea syndrome
VCAM-1
ICAM-1
epicardial fat thickness
SCORE2
title Increased Levels of VCAM-1 in Patients with High Cardiovascular Risk and Obstructive Sleep Apnea Syndrome
title_full Increased Levels of VCAM-1 in Patients with High Cardiovascular Risk and Obstructive Sleep Apnea Syndrome
title_fullStr Increased Levels of VCAM-1 in Patients with High Cardiovascular Risk and Obstructive Sleep Apnea Syndrome
title_full_unstemmed Increased Levels of VCAM-1 in Patients with High Cardiovascular Risk and Obstructive Sleep Apnea Syndrome
title_short Increased Levels of VCAM-1 in Patients with High Cardiovascular Risk and Obstructive Sleep Apnea Syndrome
title_sort increased levels of vcam 1 in patients with high cardiovascular risk and obstructive sleep apnea syndrome
topic cardiovascular risk
obstructive sleep apnea syndrome
VCAM-1
ICAM-1
epicardial fat thickness
SCORE2
url https://www.mdpi.com/2227-9059/12/1/48
work_keys_str_mv AT ioanamariachetan increasedlevelsofvcam1inpatientswithhighcardiovascularriskandobstructivesleepapneasyndrome
AT stefancristianvesa increasedlevelsofvcam1inpatientswithhighcardiovascularriskandobstructivesleepapneasyndrome
AT biancadomokosgergely increasedlevelsofvcam1inpatientswithhighcardiovascularriskandobstructivesleepapneasyndrome
AT ruxandrastefanabeyer increasedlevelsofvcam1inpatientswithhighcardiovascularriskandobstructivesleepapneasyndrome
AT ralucatomoaia increasedlevelsofvcam1inpatientswithhighcardiovascularriskandobstructivesleepapneasyndrome
AT georgianacabau increasedlevelsofvcam1inpatientswithhighcardiovascularriskandobstructivesleepapneasyndrome
AT damianamariavulturar increasedlevelsofvcam1inpatientswithhighcardiovascularriskandobstructivesleepapneasyndrome
AT danapop increasedlevelsofvcam1inpatientswithhighcardiovascularriskandobstructivesleepapneasyndrome
AT doinatodea increasedlevelsofvcam1inpatientswithhighcardiovascularriskandobstructivesleepapneasyndrome